These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33568988)

  • 21. Best early-onset Parkinson dementia predictor using ensemble learning among Parkinson's symptoms, rapid eye movement sleep disorder, and neuropsychological profile.
    Byeon H
    World J Psychiatry; 2020 Nov; 10(11):245-259. PubMed ID: 33269221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson's disease.
    Junaid M; Ali S; Eid F; El-Sappagh S; Abuhmed T
    Comput Methods Programs Biomed; 2023 Jun; 234():107495. PubMed ID: 37003039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of cardiovascular risk on disease progression in
    Oosterwegel MJ; Krijthe JH; den Brok MGHE; van den Heuvel L; Richard E; Heskes T; Bloem BR; Evers LJW
    Front Neurol; 2023; 14():1138546. PubMed ID: 37122316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal Fluid Amyloid β1-42, Tau, and Alpha-Synuclein Predict the Heterogeneous Progression of Cognitive Dysfunction in Parkinson's Disease.
    Kang JH
    J Mov Disord; 2016 May; 9(2):89-96. PubMed ID: 27240810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progression of MDS-UPDRS Scores Over Five Years in De Novo Parkinson Disease from the Parkinson's Progression Markers Initiative Cohort.
    Holden SK; Finseth T; Sillau SH; Berman BD
    Mov Disord Clin Pract; 2018; 5(1):47-53. PubMed ID: 29662921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on the Clinical Features of Parkinson's Disease With Probable Rapid Eye Movement Sleep Behavior Disorder.
    Long K; Wan C; Xiang Y; Liu J; Xu Q; Sun Q; Wang Z; Tian Y; Fang L; Yang Y; Yan X; Tang B; Guo J
    Front Neurol; 2020; 11():979. PubMed ID: 33041969
    [No Abstract]   [Full Text] [Related]  

  • 27. Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study.
    Suzuki K; Okuma Y; Uchiyama T; Miyamoto M; Sakakibara R; Shimo Y; Hattori N; Kuwabara S; Yamamoto T; Kaji Y; Hirano S; Kadowaki T; Hirata K;
    J Neurol Neurosurg Psychiatry; 2017 Nov; 88(11):953-959. PubMed ID: 28847794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Artificial Neural Network-Based Prediction of Outcome in Parkinson's Disease Patients Using DaTscan SPECT Imaging Features.
    Tang J; Yang B; Adams MP; Shenkov NN; Klyuzhin IS; Fotouhi S; Davoodi-Bojd E; Lu L; Soltanian-Zadeh H; Sossi V; Rahmim A
    Mol Imaging Biol; 2019 Dec; 21(6):1165-1173. PubMed ID: 30847821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson's disease: an 8-year follow-up study.
    Kim R; Kang N; Byun K; Park K; Jun JS
    J Neurol Neurosurg Psychiatry; 2023 Dec; 94(12):1040-1046. PubMed ID: 37451695
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Portable objective assessment of upper extremity motor function in Parkinson's disease.
    Chahine LM; Uribe L; Hogarth P; McNames J; Siderowf A; Marek K; Jennings D
    Parkinsonism Relat Disord; 2017 Oct; 43():61-66. PubMed ID: 28747279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of motor progression in Parkinson's disease using wearable sensors and machine learning.
    Sotirakis C; Su Z; Brzezicki MA; Conway N; Tarassenko L; FitzGerald JJ; Antoniades CA
    NPJ Parkinsons Dis; 2023 Oct; 9(1):142. PubMed ID: 37805655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression.
    Jackson H; Anzures-Cabrera J; Taylor KI; Pagano G; ;
    Front Neurosci; 2021; 15():765765. PubMed ID: 34966256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of novel hybrid machine learning systems and radiomics features for non-motor outcome prediction in Parkinson's disease.
    Salmanpour MR; Bakhtiyari M; Hosseinzadeh M; Maghsudi M; Yousefirizi F; Ghaemi MM; Rahmim A
    Phys Med Biol; 2023 Jan; 68(3):. PubMed ID: 36595257
    [No Abstract]   [Full Text] [Related]  

  • 35. Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.
    Brumm MC; Siderowf A; Simuni T; Burghardt E; Choi SH; Caspell-Garcia C; Chahine LM; Mollenhauer B; Foroud T; Galasko D; Merchant K; Arnedo V; Hutten SJ; O'Grady AN; Poston KL; Tanner CM; Weintraub D; Kieburtz K; Marek K; Coffey CS;
    J Parkinsons Dis; 2023; 13(6):899-916. PubMed ID: 37458046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolution of prodromal parkinsonian features in a cohort of
    Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
    J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease.
    Salmanpour MR; Shamsaei M; Saberi A; Setayeshi S; Klyuzhin IS; Sossi V; Rahmim A
    Comput Biol Med; 2019 Aug; 111():103347. PubMed ID: 31284154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
    Kim D; Paik JH; Shin DW; Kim HS; Park CS; Kang JH
    Exp Neurobiol; 2014 Dec; 23(4):352-64. PubMed ID: 25548535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients.
    Klietz M; Schnur T; Drexel S; Lange F; Tulke A; Rippena L; Paracka L; Dressler D; Höglinger GU; Wegner F
    Parkinsons Dis; 2020; 2020():5184084. PubMed ID: 32184980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing Objective and Subjective Measures of Parkinson's Disease Using the Parkinson's KinetiGraph.
    Knudson M; Thomsen TH; Kjaer TW
    Front Neurol; 2020; 11():570833. PubMed ID: 33250843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.